Related Experiment Video
Updated: Jul 14, 2026

Forward Genetic Approaches in Chlamydia trachomatis
Published on: October 24, 2013
The 32-kDa glycoprotein of Chlamydia trachomatis is an acidic protein that may be involved in the attachment process
1Department of Pathobiology, University of Washington, Seattle 98195.
Abstract:
The 32-kDa glycoprotein of Chlamydia trachomatis was shown to have a pI of 6.2 to 6.4 which distinguished this protein from the chlamydial histone-like protein of similar molecular mass that has a pI of > 10. The initial interaction of the glycan of 32 kDa glycoprotein and HeLa cells was also investigated. Glycan was cleaved from the protein backbone by N-glycanase and radiolabeled with tritium by sodium borohydride reduction. Competition assays showed the binding of glycan to HeLa cells was inhibited by galactose, mannose, and N-acetylglucosamine but not by sedoheptulose and fructose. Untreated and UV-treated organisms inhibited the binding, while heat-inactivated organisms did not. Binding was blocked by rabbit antiserum against whole organisms but not by rabbit anti-155-kDa antiserum or monoclonal antibodies against the lipopolysaccharide and major outer membrane protein.
Insights
The 32-kDa glycoprotein of Chlamydia trachomatis binds to HeLa cells via its glycan component. This interaction is inhibited by specific sugars and live or UV-treated bacteria, suggesting a role in host cell adhesion.
Area of Science:
- Microbiology
- Cell Biology
- Glycobiology
Background:
- Chlamydia trachomatis is an obligate intracellular bacterium that causes various human diseases.
- The 32-kDa glycoprotein is a major outer membrane component of Chlamydia trachomatis.
- Understanding the initial interaction between Chlamydia trachomatis and host cells is crucial for developing effective treatments.
Purpose of the Study:
- To characterize the 32-kDa glycoprotein of Chlamydia trachomatis.
- To investigate the role of the glycan moiety of the 32-kDa glycoprotein in the initial interaction with HeLa cells.
- To identify specific host cell receptors or bacterial components involved in this interaction.
Main Methods:
- Isoelectric focusing (pI) was used to distinguish the 32-kDa glycoprotein from other chlamydial proteins.
- Glycans were enzymatically cleaved from the 32-kDa glycoprotein using N-glycanase.
- Radiolabeling with tritium and sodium borohydride reduction was performed on the cleaved glycans.
- Competition assays were conducted using various sugars and different forms of Chlamydia trachomatis (untreated, UV-treated, heat-inactivated) to assess binding to HeLa cells.
- Inhibition studies involved using antisera against whole organisms and specific chlamydial components, as well as monoclonal antibodies.
Main Results:
- The 32-kDa glycoprotein exhibited an isoelectric point (pI) of 6.2–6.4, differentiating it from the chlamydial histone-like protein (pI > 10).
- Binding of the glycan to HeLa cells was inhibited by galactose, mannose, and N-acetylglucosamine, but not by sedoheptulose or fructose.
- Live and UV-treated Chlamydia trachomatis inhibited glycan binding, whereas heat-inactivated organisms did not.
- Binding was blocked by antiserum against whole organisms but not by anti-155-kDa antiserum or antibodies against lipopolysaccharide or major outer membrane protein.
Conclusions:
- The glycan portion of the 32-kDa glycoprotein of Chlamydia trachomatis plays a significant role in the initial attachment to HeLa cells.
- Specific carbohydrate structures (galactose, mannose, N-acetylglucosamine) are involved in this interaction.
- The binding appears to be mediated by live or UV-inactivated bacterial components, suggesting a biologically relevant interaction rather than a non-specific adherence.
- The interaction is likely mediated by surface structures other than lipopolysaccharide or the major outer membrane protein.
More Related Videos
07:42Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells
Published on: October 13, 2015
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
Related Concept Videos
Clathrin Coated Vesicles
Matrix Proteoglycans and Glycoproteins
Glycocalyx and its Functions
Components of...
Mechanism of Conjugation
Bacterial Phylum Chlamydiae
Trichomoniasis